ArticleCancer medicine2026

Association of the PD-L1 CPS With the Efficacy of First-Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer.

Nozomu Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.